When Will Moderna Stock Be a Screaming Buy?
Moderna (NASDAQ: MRNA) is now far below its peak market cap last summer of nearly $200 billion. In this Motley Fool Live video recorded on Jan. 5, Fool contributors Keith Speights and Brian Orelli discuss how low Moderna needs to go to make the stock a clear bargain. Keith Speights: Now, another company has already been a huge winner with COVID-19 and I'm talking about Moderna.